Novo's kidney disease drug fails to improve blood pressure in phase 3, spurring $816M loss 0 26.06.2024 20:12 Fiercebiotech.com Novo's kidney disease drug fails to improve blood pressure in phase 3, spurring $816M loss gmasson Wed, 06/26/2024 - 13:12